Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Chagas Cardiomyopathy, Non-sustained Ventricular Tachycardia or At Least 10 Points in Rassi Risk Score for Death
and you are
between 18 and 75
years old
The phase for this study is not defined.
Show me locations

The purpose

The primary objective is to compare the efficacy of the treatment using implantable cardioverter defibrillator (ICD) implantation to that of the treatment using amiodarone in the primary prevention of all-cause mortality in high-risk patients with Chagas cardiomyopathy and non-sustained ventricular tachycardia (NSVT).

Provided treatments

  • Procedure: ICD implantation
  • Drug: amiodarone hydrochloride
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01722942. The sponsor of the trial is InCor Heart Institute and it is looking for 1100 volunteers for the current phase.
Official trial title:
CHronic Use of Amiodarone aGAinSt Implantable Cardioverter-defibrillator Therapy for Primary Prevention of Death in Patients With Chagas Cardiomyopathy Study (CHAGASICS)